SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-282722
Filing Date
2023-11-24
Accepted
2023-11-24 13:46:01
Documents
13
Period of Report
2023-11-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d482680d8k.htm   iXBRL 8-K 27656
  Complete submission text file 0001193125-23-282722.txt   185534

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA celu-20231121.xsd EX-101.SCH 3858
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20231121_def.xml EX-101.DEF 13637
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20231121_lab.xml EX-101.LAB 22550
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20231121_pre.xml EX-101.PRE 14605
7 EXTRACTED XBRL INSTANCE DOCUMENT d482680d8k_htm.xml XML 5334
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 231436373
SIC: 2834 Pharmaceutical Preparations